Abundance International (SGX:541) established a new subsidiary, Abundance Specialty Chemicals, according to a Friday filing with the Singapore Exchange.
The subsidiary's main activities will be the distribution and trading of chemicals, chemical products and chemicals derived products.
Abundance Specialty has also entered into a license agreement with Molecular Targeting Technologies to develop and commercialize formulation of CypH-11, which detects viable tumor cells.
Under the agreement, Abundance Specialty will pay an upfront license fee of $125,000 and then an additional payment of $125,000.